DGEM guidelines enteral nutrition: Gastroenterology;DGEM-leitlinie enterale ernährung: Gastroenterologie

Aktuelle Ernahrungsmedizin

Volumn 28, Issue SUPPL. 1, 2003, Pages

  Lübke, Heinrich ^a   Meier, R ^f   Lochs, H ^b   Bischoff, S ^c   Engelmann, N ^f   Thul, P ^b   Loser C ^d   Keim, V ^e  

^a MARTIN LUTHER KRANKENHAUS   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d Rotes Kreuz Krankenhaus Kassel   (Germany)

^e UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^f NONE

Author keywords

Crohn's disease; Enteral nutrition; Food allergy; Malnutrition; Pancreatitis; Short bowel syndrome; Ulcerative colitis

Indexed keywords

CHRONIC PANCREATITIS; CROHN DISEASE; ENTERIC FEEDING; FOOD ALLERGY; GASTROENTEROLOGY; GERMANY; MALNUTRITION; MEDICAL LITERATURE; MEDICAL PRACTICE; PANCREATITIS; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; SHORT BOWEL SYNDROME; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; ULCERATIVE COLITIS;

EID: 0037280456     PISSN: 03410501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (192)

1. Motil KJ, Grand RJ, Maletskos CJ, Young VR. The effect of disease, drug, and diet on whole body protein metabolism in adolescents with Crohn disease and growth failure. J Pediatr 1982; 101: 345-351
2. Rosenberg IH, Bengoa JM, Sitrin MD. Nutritional aspects of inflammatory bowel disease. Annu Rev Nutr 1985; 5: 463-484
3. Heatley RV. Assessing nutritional state in inflammatory bowel disease. Gut 1986; 27, Suppl 1: 61-66
4. Beeken WL, Busch HJ, Sylwester DL. Intestinal protein loss in Crohn's disease. Gastroenterology 1972; 62: 207-215
5. Kanof ME, Lake AM, Bayless TM. Decreased height velocity in children and adolescents before the diagnosis of Crohn's disease. Gastroenterology 1988; 95: 1523-1527
6. Seidman EG. Nutritional management of inflammatory bowel disease. Gastroenterol Clin North Am 1989; 18: 129-155
7. Seidman E, LeLeiko N, Ament M et al. Nutritional issues in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1991; 12: 424-438
8. Belli DC, Seidman E, Bouthillier L et al. Chronic intermittent elemental diet improves growth failure in children with Crohn's disease. Gastroenterology 1988; 94: 603-610
9. Markowitz J, Grancher K, Rosa J, Aiges H, Daum F. Growth failure in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1993; 16: 373-380
10. Kirschner BS. Growth and development in chronic inflammatory bowel disease. Acta Paediatr Scand 1990; 366, Suppl: 98-104
11. Hildebrand H, Karlberg J, Kristiansson B. Longitudinal growth in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1994; 18: 165-173
12. Lashner BA. Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis. J Cancer Res Clin Oncol 1993; 119: 549-554
13. Aiges H, Markowitz J, Rosa J, Daum F. Home nocturnal supplemental nasogastric feedings in growth-retarded adolescents with Crohn's disease. Gastroenterology 1989; 97: 905-910
14. Chan AT, Fleming CR, O'Fallon WM, Huizenga KA. Estimated versus measured basal energy requirements in patients with Crohn's disease. Gastroenterology 1986; 91: 75-78
15. Sjogren A, Floren CH, Nilsson A. Evaluation of magnesium status in Crohn's disease as assessed by intracellular analysis and intravenous magnesium infusion. Scand J Gastroenterol 1988; 23: 555-561
16. Geerling BJ, Badart-Smook A, Stockbrugger RW, Brummer RJ. Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr 1998; 67: 919-926
17. Rath HC, Caesar I, Roth M, Scholmerich J. Nutritional deficiencies and complications in chronic inflammatory bowel diseases. Med Klin 1998; 93: 6-10
18. Maier-Dobersberger T, Lochs H. Enteral supplementation of phosphate does not prevent hypophosphatemia during refeeding of cachectic patients. JPEN J Parenter Enteral Nutr 1994; 18: 182-184
19. Vogelsang H, Schofl R, Tillinger W, Ferenci P, Gangl A. 25-hydroxyvitamin D absorption in patients with Crohn's disease and with pancreatic insufficiency. Wien Klin Wochenschr 1997; 109: 678-682
20. Schoon EJ, Muller MC, Vermeer C, Schurgers LJ, Brummer RJ, Stockbrugger RW. Low serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor of osteoporosis in Crohn's disease? Gut 2001; 48: 473-477
21. Saitoh O, Matsumoto H, Sugimori K et al. Intestinal protein loss and bleeding assessed by fecal hemoglobin, transferrin, albumin, and alpha-1-antitrypsin levels in patients with colorectal diseases. Digestion 1995; 56: 67-75
22. Becker K, Niederau C, Frieling T. Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease. Z Gastroenterol 1999; 37: 597-605
23. Hundegger K, Stufler M, Karbach U. Enteric protein loss as a marker of intestinal inflammatory activity in Crohn's disease: comparability of enteric clearance and stool concentration of alpha-1-antitrypsin? Z Gastroenterol 1992; 30: 722-728
24. Mingrone G, Benedetti G, Capristo E et al. Twenty-four-hour energy balance in Crohn disease patients: metabolic implications of steroid treatment. Am J Clin Nutr 1998; 67: 118-123
25. Stokes MA, Hill GL. Total energy expenditure in patients with Crohn's disease: measurement by the combined body scan technique. JPEN J Parenter Enteral Nutr 1993; 17: 3-7
26. O'Morain C, Segal AM, Levi AJ, Valman HB. Elemental diet in acute Crohn's disease. Arch Dis Child 1983; 58: 44-47
27. Azcue M, Rashid M, Griffiths A, Pencharz PB. Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and treatment with prednisolone. Gut 1997; 41: 203-208
28. Rigaud D, Cerf M, Angel AL, Sobhani I, Carduner MJ, Mignon M. Increase of resting energy expenditure during flare-ups in Crohn disease. Gastroenterol Clin Biol 1993; 17: 932-937
29. Schneeweiss B, Lochs H, Zauner C et al. Energy and substrate metabolism in patients with active Crohn's disease. J Nutr 1999; 129: 844-848
30. Muller MJ, Schmidt LU, Korber J, von zur MA, Canzler H, Schmidt FW. Reduced metabolic efficiency in patients with Crohn's disease. Dig Dis Sci 1993; 38: 2001-2009
31. Barot LR, Rombeau JL, Feurer ID, Mullen JL. Caloric requirements in patients with inflammatory bowel disease. Ann Surg 1982; 195: 214-218
32. Geerling BJ, Badart-Smook A, Stockbrugger RW, Brummer RJ. Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls. Eur J Clin Nutr 2000; 54: 514-521
33. Semeao EJ, Jawad AF, Stouffer NO, Zemel BS, Piccoli DA, Stallings VA. Risk factors for low bone mineral density in children and young adults with Crohn's disease. J Pediatr 1999; 135: 593-600
34. Issenman RM. Bone mineral metabolism in pediatric inflammatory bowel disease. Inflamm Bowel Dis 1999; 5: 192-199
35. Capristo E, De Gaetano A, Mingrone G et al. Multivariate identification of metabolic features in inflammatory bowel disease. Metabolism 1999; 48: 952-956.
36. Harries AD, Brown R, Heatley RV, Williams LA, Woodhead S, Rhodes J. Vitamin D status in Crohn's disease: association with nutrition and disease activity. Gut 1985; 26: 1197-1203
37. Haugeberg G, Vetvik K, Stallemo A, Bitter H, Mikkelsen B, Stokkeland M. Bone density reduction in patients with Crohn disease and associations with demographic and disease variables: cross-sectional data from a population-based study. Scand J Gastroenterol 2001; 36: 759-765
38. Bernstein CN, Seeger LL, Sayre JW, Anton PA, Artinian L, Shanahan F. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Miner Res 1995; 10: 250-256
39. Stockbrugger RW, Schoon EJ, Bollani S et al. Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease. Aliment Pharmacol Ther 2002; 16: 1519-1527
40. Klaus J, Armbrecht G, Steinkamp M et al. High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease. Gut 2002; 51: 654-658
41. Habtezion A, Silverberg MS, Parkes R, Mikolainis S, Steinhart AH. Risk factors for low bone density in Crohn's disease. Inflamm Bowel Dis 2002; 8: 87-92
42. Bernstein CN, Blanchard JF, Leslie W, Wajda A, Yu BN. The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann Intern Med 2000; 133: 795-799
43. Cucino C, Sonnenberg A. Cause of death in patients with inflammatory bowel disease. Inflamm Bowel Dis 2001; 7: 250-255
44. Lindor KD, Fleming CR, Ilstrup DM. Preoperative nutritional status and other factors that influence surgical outcome in patients with Crohn's disease. Mayo Clin Proc 1985; 60: 393-396
45. Higgens CS, Keighley MR, Allan RN. Impact of preoperative weight loss and body composition changes on postoperative outcome in surgery for inflammatory bowel disease. Gut 1984; 25: 732-736
46. Motil KJ, Grand RJ, Davis-Kraft L, Ferlic LL, Smith EO. Growth failure in children with inflammatory bowel disease: a prospective study. Gastroenterology 1993; 105: 681-691
47. Messori A, Trallori G, D'Albasio G, Milla M, Vannozzi G, Pacini F. Defined-formula diets versus steroids in the treatment of active Crohn's disease: a meta-analysis. Scand J Gastroenterol 1996; 31: 267-272
48. Griffiths AM, Ohlsson A, Sherman PM, Sutherland LR. Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology 1995; 108: 1056-1067
49. Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for inducing remission of Crohn's disease. Cochrane Database Syst Rev, 2001; 3 CD 000542
50. O'Morain C, Segal AW, Levi AJ. Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. Br Med J (Clin Res Ed) 1984; 288: 1859-1862
51. Gorard DA, Hunt JB, Payne-James JJ et al. Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone. Gut 1993; 34: 1198-1202
52. Lindor KD, Fleming CR, Burnes JU, Nelson JK, Ilstrup DM. A randomized prospective trial comparing a defined formula diet, corticosteroids, and a defined formula diet plus corticosteroids in active Crohn's disease. Mayo Clin Proc 1992; 67: 328-333
53. Gonzalez-Huix F, de Leon R, Fernandez-Banares F et al. Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial. Gut 1993; 34: 778-782
54. Malchow H, Steinhardt HJ, Lorenz-Meyer H et al. Feasibility and effectiveness of a defined-formula diet regimen in treating active Crohn's disease. European Cooperative Crohn's Disease Study III. Scand J Gastroenterol 1990; 25: 235-244
55. Lochs H, Steinhardt HJ, Klaus-Wentz B et al. Comparison of enteral nutrition and drug treatment in active Crohn's disease. Results of the European Cooperative Crohn's Disease Study. IV. Gastroenterology 1991; 101: 881-888
56. Seidman E, Griffiths A, Jones A, Issenman R. Semielemental diet versus prednisone in the treatment of active Crohns's disease in children and adolescents. Gastroenterology 1993; 104: A778 (Abstract)
57. Le Quintrec Y, Cosnes J, Le Quintrec M et al. Exclusive elemental enteral diet in cortico-resistant and cortico-dependent forms of Crohn's disease. Gastroenterol Clin Biol 1987; 11: 477-482
58. Greenberg GR, Fleming CR, Jeejeebhoy KN, Rosenberg IH, Sales D, Tremaine WJ. Controlled trial of bowel rest and nutritional support in the management of Crohn's disease. Gut 1988; 29: 1309-1315
59. Lochs H, Egger-Schödl M, Pötzi R, Kappel CH, Schuh R. Enterale Ernährung - eine Alternative zur parenteralen Ernährung in der Behandlung von Morbus Crohn? Leber, Magen, Darm 1984; 14: 64-67
60. Lochs H, Meryn S, Marosi L, Ferenci P, Hörtnagl H. Has total bowel rest a beneficial effect in the treatment of Crohn's Disease? Clin Nutr 1983; 2: 61-64
61. Wright RA, Adler EC. Peripheral parenteral nutrition is no better than enteral nutrition in acute exacerbation of Crohn's disease: a prospective trial. J Clin Gastroenterol 1990; 12: 396-399
62. Verma S, Kirkwood B, Brown S, Giaffer MH. Oral nutritional supplementation is effective in the maintenance of remission in Crohn's disease. Dig Liver Dis 2000; 32: 769-774
63. Wilschanski M, Sherman P, Pencharz P, Davis L, Corey M, Griffiths A. Supplementary enteral nutrition maintains remission in paediatric Crohn's disease. Gut 1996; 38: 543-548
64. Hirakawa H, Fukuda Y, Tanida N, Hosomi M, Shimoyama T. Home elemental enteral hyperalimentation (HEEH) for the maintenance of remission in patients with Crohn's disease. Gastroenterol Jpn 1993; 28: 379-384
65. Royall D, Jeejeebhoy KN, Baker JP et al. Comparison of amino acid v peptide based enteral diets in active Crohn's disease: clinical and nutritional outcome. Gut 1994; 35: 783-787
66. Harries AD, Jones LA, Danis V et al. Controlled trial of supplemented oral nutrition in Crohn's disease. Lancet 1983; 1: 887-890
67. Blondel - Kucharski F, Chircop C, Marquis P et al. Health-related quality of life in Crohn's disease: a prospective longitudinal study in 231 patients. Am J Gastroenterol 2001; 96: 2915-2920
68. Malone M. Quality of life of patients receiving home parenteral or enteral nutrition support. Pharmacoeconomics 1994; 5: 101-108
69. Rees RG, Keohane PP, Grimble GK, Frost PG, Attrill H, Silk DB. Elemental diet administered nasogastrically without starter regimens to patients with inflammatory bowel disease. JPEN J Parenter Enteral Nutr 1986; 10: 258-262
70. Mahajan L, Oliva L, Wyllie R, Fazio V, Steffen R, Kay M. The safety of gastrostomy in patients with Crohn's disease. Am J Gastroenterol 1997; 92: 985-988
71. Cosgrove M, Jenkins HR. Experience of percutaneous endoscopic gastrostomy in children with Crohn's disease. Arch Dis Child 1997; 76: 141-143
72. Anstee QM, Forbes A. The safe use of percutaneous gastrostomy for enteral nutrition in patients with Crohn's disease. Eur J Gastroenterol Hepatol 2000; 12: 1089-1093
73. Verma S, Brown S, Kirkwood B, Giaffer MH. Polymeric versus elemental diet as primary treatment in active Crohn's disease: a randomized, double-blind trial. Am J Gastroenterol 2000; 95: 735-739
74. Mansfield JC, Giaffer MH, Holdsworth CD. Controlled trial of oligopeptide versus amino acid diet in treatment of active Crohn's disease. Gut 1995; 36: 60-66
75. Park HR, Galloway A, Danesh JZD, Russell R. Double-blind controlled trial of elemental and polymeric diets as primary therapy in actice Crohn's disease. Eur J Gastroenterol Hepatol 1991; 3: 483-490
76. Middleton SJ, Riordan AM, Hunter. Comparison of elemental and peptide-based diets in the treatment of acute Crohn's disease. Ital J Gastroenterol 1991; 23: 609A
77. Raouf AH, Hildrey V, Daniel J et al. Enteral feeding as sole treatment for Crohn's disease: controlled trial of whole protein v amino acid based feed and a case study of dietary challenge. Gut 1991; 32: 702-707
78. Rigaud D, Cosnes J, Le Quintrec Y, Rene E, Gendre JP, Mignon M. Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease: elemental versus polymeric diet. Gut 1991; 32: 1492-1497
79. Sakurai T, Matsui T, Yao T et al. Short-term efficacy of enteral nutrition in the treatment of active Crohn's disease: a randomized, controlled trial comparing nutrient formulas. JPEN J Parenter Enteral Nutr 2002; 26: 98-103
80. Khoshoo V, Reifen R, Neuman MG, Griffiths A, Pencharz PB. Effect of low- and high-fat, peptide-based diets on body composition and disease activity in adolescents with active Crohn's disease. JPEN J Parenter Enteral Nutr 1996; 20: 401-405
81. Gassull MA, Fernandez-Banares F, Cabre E et al. Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial. Gut 2002; 51: 164-168
82. Akobeng AK, Miller V, Stanton J, Elbadri AM, Thomas AG. Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease. J Pediatr Gastroenterol Nutr 2000; 30: 78-84
83. Den Hond E, Hiele M, Peeters M, Ghoos Y, Rutgeerts P. Effect of long-term oral glutamine supplements on small intestinal permeability in patients with Crohn's disease. JPEN J Parenter Enteral Nutr 1999; 23: 7-11
84. Beattie RM, Schiffrin EJ, Donnet-Hughes A et al. Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease. Aliment Pharmacol Ther 1994; 8: 609-615
85. Fell JM, Paintin M, Arnaud-Battandier F et al. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther 2000; 14: 281-289
86. Capristo E, Mingrone G, Addolorato G, Greco AV, Gasbarrini G. Metabolic features of inflammatory bowel disease in a remission phase of the disease activity. J Intern Med 1998; 243: 339-347
87. Klein S, Meyer S, O'Sullivan P. The metabolic impact of active ulcerative colitis. Energy expenditure and nitrogen balance. J Clin Gastroenterol 1988; 10: 34-40
88. Schreiber J, Shurin SB. Oral care with vancomycin paste for alpha-hemolytic streptococcal sepsis. J Pediatr Hematol Oncol 1996; 18: 334
89. Rath HC, Caesar I, Roth M, Scholmerich J. Nutritional deficiencies and complications in chronic inflammatory bowel diseases. Med Klin 1998; 93: 6-10
90. Franklin JL, Rosenberg HH. Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyridine (Azulfidine). Gastroenterology 1973; 64: 517-525
91. Lashner BA. Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis. J Cancer Res Clin Oncol 1993; 119: 549-554
92. Boot AM, Bouquet J, Krenning EP, de Muinck Keizer-Schrama SM. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. Gut 1998; 42: 188-194
93. Jahnsen J, Falch JA, Aadland E, Mowinckel P. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut 1997; 40: 313-319
94. Brandes JW, Stenner A, Martini GA. Dietary habits of patients with ulcerative colitis. Z Gastroenterol 1997; 17: 834-842
95. Jones LA, Harries AD, Rhodes J, Heatley RV. Normal energy intake in undernourished patients with Crohn's disease. Br Med J (Clin Res Ed) 1984; 288: 193
96. Tragnone A, Valpiani D, Miglio F et al. Dietary habits as risk factors for inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995; 7: 47-51
97. Rocchio MA, Cha CJ, Haas KF, Randall HT. Use of chemically defined diets in the management of patients with acute inflammatory bowel disease. Am J Surg 1974; 127: 469-475
98. Axelsson C, Jarnum S. Assessment of the therapeutic value of an elemental diet in chronic inflammatory bowel disease. Scand J Gastroenterol 1977; 12: 89-95
99. McIntyre PB, Powell-Tuck J, Wood SR et al. Controlled trial of bowel rest in the treatment of severe acute colitis. Gut 1986; 27: 481-485
100. Gonzalez-Huix F, Fernandez-Banares F, Esteve-Comas M et al. Enteral versus parenteral nutrition as adjunct therapy in acute ulcerative colitis. Am J Gastroenterol 1993; 88: 227-232
101. Stenson WF, Cort D, Rodgers J et al. Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med 1992; 116: 609-614
102. Hawthorne AB, Daneshmend TK, Hawkey CJ et al. Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut 1992; 33: 922-928
103. Loeschke K, Ueberschaer B, Pietsch A et al. N-3 fatty acids only delay early relapse of ulcerative colitis in remission. Dig Dis Sci 1996; 41: 2087-2094
104. Purdum PP, Kirby DF. Short-bowel syndrome: a review of the role o nutrition support. JPEN J Parenter Enteral Nutr 1991; 15: 93-101
105. Marotta R, Floch MH. Dietary therapy of steatorhoea. Gastroenterol Clin North Am 1993; 18: 485-508
106. Nightingale JM, Lennard-Jones JE. The short bowel syndrome: what's new and old? Dig Dis 1993; 11: 12-31
107. Messing B, Pigot F, Rongier M, Morin MC, Ndeindoum U, Rambaud JC. Intestinal absorption of free oral hyperalimentation in the very short bowel syndrome. Gastroenterology 1991; 100: 1502-1508
108. Jeppesen PB, Mortensen PB. Intestinal failure defined by measurements of intestinal energy and wet weight absorption. Gut 2000; 46: 701-706
109. Woolf GM, Miller C, Kurian R, Jeejeebhoy KN. Nutritional absorption in short bowel syndrome. Evaluation of fluid, calorie, and divalent cation requirements. Dig Dis Sci 1987; 32: 8-15
110. Nordgaard I, Hansen BS, Mortensen PB. Colon as a digestive organ in patient with short bowel. Lancet 1994; 343: 373-376
111. Ovensen L, Chu R, Howard L. The influence of dietary fat on jejunostomy output in patients with severe short bowel syndrome. Am J Clin Nutr 1983; 38: 270-278
112. Cosnes J, Gendre JP, Evard D, Le Quintrec Y. Compensatory enteral hyperalimentation for management of patients with severe short bowel syndrome. Am J Clin Nutr 1985; 41: 1002-1009
113. Booth IW. Enteral nutrition as primary therapy in short bowel syndrome. Gut 1994; 35: S69-S72
114. Carbonnel F, Cosnes J, Chevret S et al. The role of anatomic factors in nutritional autonomy after extensive small bowel resection. JPEN J Parenter Enteral Nutr 1996; 20: 275-280
115. Rabast U. Ernährungstherapie beim Kurzdarmsyndrom. Akt Ernaehr Med 1997; 22: 103-111
116. Rodriguez DJ, Clevenger FW. Successful enteral refeeding after massive small bowel resection. West J Med 1993; 159: 192-194
117. Dudrick SJ, Latifi R, Fosnocht DE. Management of the short-bowel syndrome. Surg Clin North Am 1991; 71: 625-643
118. Griffin GE, Fagan EF, Hodgson HJ, Chadwick VS. Enteral therapy in the management of massive gut resection complicated by chronic fluid and electrolyte depletion. Dig Dis Sci 1982; 27: 902-908
119. Lennard-Jones JE. Review article: practical management of the short bowel. Aliment Pharmacol Ther 1994; 8: 563-577
120. McIntyre PB, Fitchew M, Lennard-Jones JE. Patients with a high jejunostomy do not need a special diet. Gastroenterology 1986; 91: 25-33
121. Suchner U, Senftleben U, Eckart T et al. Enteral versus parenteral nutrition: effects on gastrointestinal function and metabolism. Nutrition 1996; 12: 13-22
122. Wicks C, Somasundaram S, Bjarnason I et al. Comparison of enteral feeding and total parenteral nutrition after liver transplantation. Lancet 1994; 344: 837-840
123. Hadfield RJ, Sinclair DG, Houldsworth PE, Evans TW. Effects of enteral and parenteral nutrition on gut mucosal permeability in the critically ill. Am J Respir Crit Care Med 1995; 152: 1545-1548
124. Reynolds JV, Kanwar S, Welsh FK et al. Does the route of feeding modify gut barrier function and clinical outcome in patients after major upper gastrointestinal surgery? JPEN J Parenter Enteral Nutr 1997; 21: 196-201
125. Hoensch HP, Steinhardt HJ, Weiss G, Haug D, Maier A, Malchow H. Effects of semisynthetic diets on xenobiotic metabolizing enzyme activity and morphology of small intestinal mucosa in humans. Gastroenterology 1984; 86: 1519-1530
126. Lipman TO. Grains or veins: is enteral nutrition really better than parenteral nutrition? A look at the evidence. JPEN J Parenter Enteral Nutr 1998; 22: 167-182
127. Cosnes J, Carbonnel F. Oral and enteral nutrition management and drug treatment of short bowel syndrome. Clin Nutr 1995; 14: 16-20
128. Wilmore DW, Robinson MK. Short bowel syndrome. World J Surg 2000; 24: 1486-1492
129. Byrne TA, Persinger RL, Young LS, Ziegler TR, Wilmore DW. A new treatment for patients with short-bowel syndrome. Growth hormone, glutamine, and a modified diet. Ann Surg 1995; 222: 243-254
130. Scolapio JS, McGreevy K, Tennyson GS, Burnett OL. Effect of glutamine in short-bowel syndrome. Clin Nutr 2001; 20: 319-323
131. Li L, Irving M. The effectiveness of growth hormone, glutamine and a low-fat diet containing high-carbohydrate on the enhancement of the function of reminant intestine among patients with short bowel syndrome: a review of published trials. Clin Nutr 2001; 20: 199-204
132. Shaw JH, Wolfe RR. Glucose, fatty acid, and urea kinetics in patients with severe pancreatitis. The response to substrate infusion and total parenteral nutrition. Ann Surg 1986; 204: 665-672
133. Dickerson RN, Vehe KL, Mullen JL, Feurer ID. Resting energy expenditure in patients with pancreatitis 1. Crit Care Med 1991; 19: 484-490
134. Bouffard YH, Delafosse BX, Annat GJ, Viale JP, Bertrand OM, Motin JP. Energy expenditure during severe acute pancreatitis 1. JPEN J Parenter Enteral Nutr 1989; 13: 26-29
135. Feller JH, Brown RA, Toussaint GP, Thompson AG. Changing methods in the treatment of severe pancreatitis 1. Am J Surg 1974; 127: 196-201
136. Sitzmann JV, Steinborn PA, Zinner MJ, Cameron JL. Total parenteral nutrition and alternate energy substrates in treatment of severe acute pancreatitis 1. Surg Gynecol Obstet 1989; 168: 311-317
137. Cameron JL, Capuzzi DM, Zuidema GD, Margolis S. Acute pancreatitis with hyperlipemia. Evidence for a persistent defect in lipid metabolism 1. Am J Med 1974; 56: 482-487
138. Cameron JL, Capuzzi DM, Zuidema GD, Margolis S. Acute pancreatitis with hyperlipemia: the incidence of lipid abnormalities in acute pancreatitis 1. Ann Surg 1973; 177: 483-489
139. Greenberger NJ. Pancreatitis and hyperlipemia 1. N Engl J Med 1973; 289: 586-587
140. Robin AP, Campbell R, Palani CK, Liu K, Donahue PE, Nyhus LM. Total parenteral nutrition during acute pancreatitis: clinical experience with 156 patients 1. World J Surg 1990; 14: 572-579
141. Sax HC, Warner BW, Talamini MA et al. Early total parenteral nutrition in acute pancreatitis: lack of beneficial effects 1. Am J Surg 1987; 153: 117-124
142. McClave SA, Greene LM, Snider HL et al. Comparison of the safety of early enteral vs parenteral nutrition in mild acute pancreatitis 4. JPEN J Parenter Enteral Nutr 1997; 21: 14-20
143. Windsor AC, Kanwar S, Li AG et al. Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis 1. Gut 1998; 42: 431-435
144. Powell JJ, Murchison JT, Fearon KC, Ross JA, Siriwardena AK. Randomized controlled trial of the effect of early enteral nutrition on markers of the inflammatory response in predicted severe acute pancreatitis 1. Br J Surg 2000; 87: 1375-1381
145. Kalfarentzos F, Kehagias J, Mead N, Kokkinis K, Gogos CA. Enteral nutrition is superior to parenteral nutrition in severe acute pancreatitis: results of a randomized prospective trial 1. Br J Surg 1997; 84: 1665-1669
146. Cravo M, Camilo ME, Marques A, Pinto Correia J. Early tube feeding in acute pancreatitis: A prospective study. Clin Nutr 1989; 8, Suppl 1: 7-14
147. Kudsk KA, Campbell SM, O'Brien T, Fuller R. Postoperative jejunal feedings following complicated pancreatitis 1. Nutr Clin Pract 1990; 5: 14-17
148. Nakad A, Piessevaux H, Marot JC et al. Is early enteral nutrition in acute pancreatitis dangerous? About 20 patients fed by an endoscopically placed nasogastrojejunal tube 1. Pancreas 1998; 17: 187-193
149. Stabile BE, Debas HT. Intravenous versus intraduodenal amino acids, fats, and glucose as stimulants of pancreatic section. Surg Forum 1981; 32: 224-226
150. Blackburn GL, Williams LF, Bistrian BR et al. New approaches to the management of severe acute pancreatitis 4. Am J Surg 1976; 131: 114-124
151. Grant JP, James S, Grabowski V, Trexler KM. Total parenteral nutrition in pancreatic disease 3. Ann Surg 1984; 200: 627-631
152. Simpson WG, Marsano L, Gates L. Enteral nutritional support in acute alcoholic pancreatitis 1. J Am Coll Nutr 1995; 14: 662-665
153. Levy P, Heresbach D, Pariente EA et al. Frequency and risk factors of recurrent pain during refeeding in patients with acute pancreatitis: a multivariate multicentre prospective study of 116 patients 1. Gut 1997; 40: 262-266
154. Neviackas JA, Kerstein MD. Pancreatic enzyme response with an elemental diet 1. Surg Gynecol Obstet 1976; 142: 71-74
155. McArdle AH, Echave W, Brown RA, Thompson AG. Effect of elemental diet on pancreatic secretion 1. Am J Surg 1974; 128: 690-692
156. Cassim MM, Allardyce DB. Pancreatic secretion in response to jejunal feeding of elemental diet. Ann Surg 1974; 180: 228-231
157. Grant JP, Davey-McCrae J, Snyder PJ. Effect of enteral nutrition on human pancreatic secretions 2. JPEN J Parenter Enteral Nutr 1987; 11: 302-304
158. Vison N, Hecketsweiler P, Butel J, Bernier JJ. Effect of continuous jejunal perfusion of elemental and complex nutritional solutions on pancreatic enzyme secretion in human subjects 1. Gut 1978; 19: 194-198
159. Ragins H, Levenson SM, Signer R, Stamford W, Seifter E. Intrajejunal administration of an elemental diet at neutral pH avoids pancreatic stimulation. Studies in dog and man 1. Am J Surg 1973; 126: 606-614
160. Trice S, Melnik G, Page CP. Complications and costs of early postoperative parenteral versus enteral nutrition in trauma patients. Nutr Clin Pract 1997; 12: 114-119
161. Heyland DK, Novak F, Drover JW, Jain M, Su X, Suchner U. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence 1. JAMA 2001; 286: 944-953
162. DiMagno EP, Go VL, Summerskill WH. Relations between pancreatic enzyme ouputs and malabsorption in severe pancreatic insufficiency 15. N Engl J Med 1973; 288: 813-815
163. DiMagno EP, Layer P. Human exocrine pankreatic enzyme secretion. In: Go VL (ed): The pancreas. Biology, pathobiology, and disease. New York: Raven Press, 1993: 275-300
164. Lanspa SJ, Chan AT, Bell JS III, Go VL, Dickson ER, DiMagno EP. Pathc genesis of steatorrhea in primary biliary cirrhosis 1. Hepatology 1985; 5: 837-842
165. Hebuterne X, Hastier P, Peroux JL, Zeboudj N, Delmont JP, Rampal P. Resting energy expenditure in patients with alcoholic chronic pancreatitis 1. Dig Dis Sci 1996; 41: 533-539
166. DiMagno EP, Clain JE, Layer P. Chronic pancreatitis. In: Go VL (ed): The pancreas. Biology, pathobiology, and disease. New York: Rave Press, 1993: 665-706
167. Twersky Y, Bank S. Nutritional deficiencies in chronic pancreatitis. Gastroenterol Clin North Am 1989; 18: 543-565
168. Steer ML, Waxman I, Freedman S. Chronic pancreatitis 4. N Engl J Me 1995; 332: 1482-1490
169. Havala T, Shronts E, Cerra F. Nutritional support in acute pancreatitis 1. Gastroenterol Clin North Am 1989; 18: 525-542
170. Holt S. Chronic pancreatitis 3. South Med J 1993; 86: 201-207
171. Latifi R, McIntosh JK, Dudrick SJ. Nutritional management of acul and chronic pancreatitis 1. Surg Clin North Am 1991; 71: 579-595
172. DiMagno EP. Medical treatment of pancreatic insufficiency 7. Mayo Clin Proc 1979; 54: 435-442
173. Scolapio JS, Malhi-Chowla N, Ukleja A. Nutrition supplementation in patients with acute and chronic pancreatitis 1. Gastroenterol Clin North Am 1999; 28: 695-707
174. Caliari S, Benini L, Sembenini C, Gregori B, Carnielli V, Vantini I. Medium-chain triglyceride absorption in patients with pancreatic insufficiency 1. Scand J Gastroenterol 1996; 31: 90-94
175. DiMagno EP, Malagelada JR, Go VL, Moertel CG. Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules 2. N Engl J Med 1977; 296: 1318-1322
176. Graham DY. Enzyme replacement therapy of exocrine pancreatic insufficiency in man. Relations between in vitro enzyme activities and in vivo potency in commercial pancreatic extracts 5. N Engl J Med 1977; 296: 1314-1317
177. Whitehead AM. Study to compare the enzyme activity, acid resistance and dissolution characteristics of currently available pancreatic enzyme preparations 1. Pharm Weekbl Sci 1988; 10: 12-16
178. Regan PT, Malagelada JR, DiMagno EP, Glanzman SL, Go VL. Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency 2. N Engl J Med 1977; 297: 854-858
179. Suzuki A, Mizumoto A, Sarr MG, DiMagno EP. Bacterial lipase and high-fat diets in canine exocrine pancreatic insufficiency: a new therapy of steatorrhea? 2. Gastroenterology 1997; 112: 2048-2055
180. Malesci A, Mariani A, Mezzi G, Bocchia P, Basilico M. New enteric-coated high-lipase pancreatic extract in the treatment of pancreatic steatorrhea 1. J Clin Gastroenterol 1994; 18: 32-35
181. Taubin HL, Spiro HM. Nutritional aspects of chronic pancreatitis 1. Am J Clin Nutr 1973; 26: 367-373
182. Heijerman HG, Lamers CB, Bakker W. Omeprazole enhances the efficacy of pancreatin (pancrease) in cystic fibrosis 3. Ann Intern Med 1991; 114: 200-201
183. Halgreen H, Pedersen NT, Worning H. Symptomatic effect of pancreatic enzyme therapy in patients with chronic pancreatitis 2. Scand J Gastroenterol 1986; 21: 104-108
184. Ramo OJ, Puolakkainen PA, Seppala K, Schroder TM. Self-administration of enzyme substitution in the treatment of exocrine pancreatic insufficiency 1. Scand J Gastroenterol 1989; 24: 688-692
185. Sampson HA. Food allergy. Part 1: Immunopathogenesis and clinical disorders. J Allergy Clin Immunol 1999; 103: 717-728
186. Bischoff SC, Manns MP. Nahrungsmittelallergien. Internist 2001; 42: 1108-1117
187. Bischoff SC, Herrmann A, Mayer J, Manns MP. Food allergy in patients with gastrointestinal disease. Monogr Allergy 1996; 32: 130-142
188. Bruijnzeel-Koomen C, Ortolani C, Aas K, Bindslev-Jensen C, Björkstén B, Moneret-Vautrin D, Wüthrich B. Adverse reactions to food. Allergy 1995; 50: 623-635
189. Schoetzau A, Gehring U, Wichmann H. Prospective cohort studies using hydrolysed formulas for allergy prevention in atopy-prone newborns: a systematic review. Eur J Pediatr 2001; 160: 323-332
190. Niggemann B, Binder C, Dupont C, Hadji S, Arvola T, Isolauri E. Prospective, controlled, multi-center study on the effect of an aminois acid-based formula in infants with cow's milk allergy/intolerance and atopic dermatitis. Pediatr Allergy Immunol 2001; 12: 78-82
191. Munkvad M, Danielsen L, Hoj L, Povlsen CO, Secher L, Svejgaard E, Bundgaard A, Larsen PO. Antigen-free diet in adult patients with atopic dermatitis. A double-blind controlled study. Acta Derm Venereol 1984; 64: 524-528
192. Hoj L, Osterballe O, Bundgaard A, Weeke B, Weiss M. A double-blind controlled trial of elemental diet in severe, perennial asthma. Allergy 1981; 36: 257-262